Free Trial

Russell Investments Group Ltd. Has $115.21 Million Position in Humana Inc. (NYSE:HUM)

Humana logo with Medical background
Remove Ads

Russell Investments Group Ltd. lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 43.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 454,072 shares of the insurance provider's stock after acquiring an additional 137,039 shares during the period. Russell Investments Group Ltd. owned approximately 0.38% of Humana worth $115,210,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Transcend Capital Advisors LLC lifted its stake in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after purchasing an additional 2,914 shares during the period. FNY Investment Advisers LLC raised its holdings in shares of Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after buying an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after acquiring an additional 65,735 shares during the period. Finally, Secure Asset Management LLC acquired a new position in Humana during the fourth quarter worth $244,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on HUM shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Guggenheim assumed coverage on shares of Humana in a report on Wednesday. They set a "buy" rating and a $326.00 price objective for the company. Truist Financial raised their price target on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a report on Friday. Barclays lifted their price target on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $286.00.

Get Our Latest Report on Humana

Humana Trading Up 0.9 %

Shares of Humana stock traded up $2.57 during trading hours on Friday, hitting $292.82. The company's stock had a trading volume of 622,751 shares, compared to its average volume of 1,744,117. The company has a market capitalization of $35.34 billion, a PE ratio of 29.46, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a 50 day moving average of $265.56 and a 200 day moving average of $270.77. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.21%. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Congress Bought THESE Stocks as Tariffs Tanked the Market

Congress Bought THESE Stocks as Tariffs Tanked the Market

Reports of congressional buying and selling during the tariff meltdown are coming in; find out which companies members of Congress bought and sold.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads